Meet the ASCP 2025 Faculty Whose Insights Will Spark Discussion, Collaboration, and Innovation

The ASCP 2025 Annual Meeting is only four months away, Nov. 17-20 in Atlanta, GA. Renowned for its distinguished faculty, whose knowledge and expertise help prepare pathologists and clinical laboratory professionals to make a significant impact on patient care, the ASCP 2025 Annual Meeting is your chance to elevate your knowledge for better patient care.  

Here is a preview of some key presentations and their faculty.   

Laboratory-Developed Tests (LDTs)—Future Directions and Lessons Learned 

With the recent federal court ruling vacating the Food and Drug Administration’s (FDA) LDT Final Rule, many in the laboratory community wonder what is next. 

Presenters Jonathan R. Genzen, MD, PhD, MBA, and Michelle Campbell, MS, MLS(ASCP)CMMB^CMSC^CM, will reflect on recent events and what the laboratory community has learned from its experiences in preparing for the now-vacated FDA LDT Final Rule.  What are the lessons learned and best practices as the laboratory community prepares to move forward? How can laboratories better prepare for future regulatory oversight frameworks? 

Dr. Genzen is the chief medical officer and senior director of government affairs at ARUP Laboratories, and professor of pathology at the University of Utah, and Ms. Campbell is the senior developer for the Translational Research, Innovation and Test Development Office at Mayo Clinic, and adjunct assistant professor at the University of North Carolina at Chapel Hill.  

Emerging and Reemerging Pathogens: An Update  

Rodney Rohde, PhD, MS, SM(ASCP)^CMSV^CMMB^CM, will focus on current and evolving threats in infectious diseases, including pathogens, such as SARS-CoV-2, mpox, pertussis, and antimicrobial-resistant organisms. He will also highlight global trends, diagnostic innovations, and the implications of public health challenges such as vaccine hesitancy and misinformation. 

This session is intended for medical laboratory scientists, pathologists, infectious disease specialists, and public health professionals, essentially anyone working at the intersection of diagnostics and disease prevention. His goal is to equip attendees with practical knowledge and a broader understanding of how these pathogens are reshaping our workflows, biosafety protocols, and the role of the laboratory in early detection and response. 

“It’s a timely topic, and I aim to both inform and empower laboratory professionals as frontline defenders in global and community health,” says Dr. Rohde, associate director for the Translational Health Research Initiative at Texas State University, in San Marcos, TX, where he is also the College of Health Professions chair and Distinguished Regents' Professor of Clinical Laboratory Science. 

Cancer Biomarker Testing Navigation: Bridging Gaps to Achieve Optimal Patient Outcomes 

This session focuses on a novel new Biomarker Testing Navigation (BTN) role and ASCP's online certificate program for cancer biomarker navigation. The expert panel, which includes Lynnette Pineault, MBA, SCT(ASCP), manager of Laboratory Operations and Genetic Counseling Services HealthPartners – Regions Hospital in St. Paul, MN, will highlight how biomarker navigation can enhance laboratory workflows to ensure patients get timely access to life-saving targeted therapies. The session is intended for individuals who currently work in this space—laboratory professionals, pathologists, leaders and support staff—who are eager to optimize cancer biomarker testing.   

“This topic is incredibly relevant today, as we navigate the rapid acceleration of precision medicine in cancer diagnosis and treatment,” Ms. Pineault says. “As the complexity of cancer biomarker testing increases, critical workflow gaps often emerge that can delay patient care. Biomarker navigation directly addresses these challenges, improving test turnaround, reducing errors, and ensuring patients receive personalized treatments quickly. It's a proactive solution to a pressing need in modern pathology.”   

The panel comprises members of the current BTN Project Advisory Committee, which Ms. Pineault chairs. “We'll unveil the rationale and innovative design of the BTN role, share compelling real-world success stories from our own experiences, and provide practical insights into how BTNs improve coordination and diagnostic stewardship.” Ms. Pineault says.    

The group will also introduce ASCP’s new virtual certificate program, Mastering Cancer Biomarker Testing Navigation.   

Why ASCP 2025 is the premier annual meeting 

The ASCP Annual Meeting stands out because of its unique integration of laboratory medicine, pathology, and public health, creating a truly interdisciplinary environment. It brings together not just scientists and clinicians, but also educators, policymakers, and innovators who are shaping the future of diagnostics and laboratory science. 

“What I find especially compelling is ASCP’s deep commitment to both cutting-edge science and professional advocacy,” Dr. Rohde says. “The meeting doesn’t just focus on technical advances—it also highlights workforce development, health equity, global health, and the critical role of medical laboratory professionals in patient care.” 

Unlike many other meetings, ASCP creates space for strategic conversations that bridge clinical practice with real-world implementation. Whether it’s antimicrobial resistance, diagnostic stewardship, or mentoring the next generation of laboratory professionals, ASCP is future-facing in a very actionable way. 

Additionally, the energy and engagement of the attendees—particularly students and early-career professionals—is exceptional. It’s a community that values both legacy and innovation. 

“Every year, I leave the meeting reenergized and proud to be part of this profession.” Dr. Rohde says. “It feels like a family reunion each and every time I’m working with ASCP and the outstanding experts and passionate laboratory professionals that compose the organization!” 

Learn more and register here.